Vaccine News and Research

Latest Vaccine News and Research

PATH to pay FDA $480,000 to speed creation of pneumococcal vaccine for developing world

The FDA on Monday said it's entering into a collaboration with the nonprofit group PATH "to speed creation of a pneumococcal vaccine for children in developing nations," United Press International reports (2/1).

3 Feb 2010

Obama's FY 2011 budget gives global health funding boost

President Barack Obama's FY 2011 budget request for global health totals $9.6 billion and includes funding for global health activities within the State Department, USAID and HHS, the Wall Street Journal reports

3 Feb 2010

Obama's budget includes a tempered vision of health reform

Democrats' health overhaul efforts are stalled in Congress, but President Obama's 2011 budget offers a "modest" back-up plan, the Associated Press reports. "The budget released Monday contains lots of respectable ideas to squeeze savings, expand coverage and improve quality, but no ambitious change that launches the nation on a path to health care for all."

2 Feb 2010

Global AIDS Alliance calls for Congress to fully fund the Global Health Initiative

President Obama's budget, transmitted to Congress this morning, includes $8.5 billion for a Global Health Initiative. Based on projections to continue supporting robust U.S. programs to fight AIDS, TB and malaria and implement GHI priorities -- $16.4 billion is required in FY2011.

2 Feb 2010

Cryogenetics invents a method for cryo-preservation of fish embryos

The Norwegian company Cryogenetics Ltd. has made a significant breakthrough by inventing a method for cryo-preservation of fish embryos down to -130° C (-202° F).

2 Feb 2010

Scientists find that protease HtrA2 can "clean" cells of oncogene WT1

Dr Jorg Hartkamp and Dr Stefan Roberts have found that the protease HtrA2 can "clean" cells of the oncogene WT1, which is found at high levels in many leukaemias and solid cancers such as breast and lung cancer.

From The University of Manchester 2 Feb 2010

New therapeutic made from tobacco plants shown to arrest West Nile virus infection

A new therapeutic made from tobacco plants has been shown to arrest West Nile virus infection, according to a new study by Arizona State University scientist Qiang Chen and his colleagues.

2 Feb 2010

President's fiscal year 2011 budget: FDA requests $4.03 billion for promoting and protecting public health

The U.S. Food and Drug Administration is requesting $4.03 billion to promote and protect public health as part of the President's fiscal year 2011 budget - a 23 percent increase over the agency's current $3.28 billion budget.

2 Feb 2010

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

"We are delighted to be working with such esteemed institutions in order to generate cutting-edge therapeutic antibodies," said Matthew Baker, chief scientific officer and co-founder of Antitope. "This agreement combines our partners' expertise in novel therapeutic strategies with Antitope's expertise in engineering humanized antibodies to create therapeutic antibodies that may have a significant impact on the treatment of these major diseases."

2 Feb 2010

FDA and PATH collaborate to advance pneumococcal vaccine development for children

The U.S. Food and Drug Administration (FDA) today announced a collaboration with PATH to advance development of a vaccine to protect children against diseases caused by Streptococcus pneumoniae (pneumococcus), especially pneumonia.

2 Feb 2010

Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds

An experimental vaccine was found to reduce the rate of tuberculosis infections in patients living with HIV, "the first time a shot has been shown to reduce cases of the most common AIDS-related cause of death in poor nations," Bloomberg reports (Bennett, 1/29). Tuberculosis accounts for up to one-third of AIDS deaths worldwide, CBC News reports.

1 Feb 2010

Romark Laboratories commences enrollment in Alinia clinical trial for acute uncomplicated influenza

Romark Laboratories announced that it has initiated enrollment of patients in a clinical trial of Alinia® (nitazoxanide) for treating acute uncomplicated influenza including illness caused by the currently circulating H1N1 strain.

1 Feb 2010

WHO pneumonia expert honored with PACE Global Leadership Award

WHO pneumonia expert Dr. Thomas Cherian will be honored by a group of the world’s leading infectious disease experts today for his pivotal work to accelerate access to vaccines preventing pneumococcal disease, the world’s leading vaccine-preventable killer of children under age five.

31 Jan 2010

PATH praises Gates Foundation for supporting vaccine development and delivery

Vaccination may be the most effective public health intervention of all time-especially in low-income countries, where many families can't access or afford health care when they are sick. On Friday, January 29, speaking at the World Economic Forum in Davos, Switzerland, Bill and Melinda Gates announced a new ten-year Gates Foundation commitment to funding vaccine development and delivery.

30 Jan 2010

New vaccine effective in preventing TB in HIV patients

Investigators from Dartmouth Medical School (DMS) have reported results of a clinical trial showing that a new vaccine against tuberculosis, Mycobacterium vaccae (MV), is effective in preventing tuberculosis in people with HIV infection.

30 Jan 2010

At World Economic Forum, Gates Foundation announces 10-year, $10B vaccine commitment

Bill and Melinda Gates announced Friday during the World Economic Forum in Davos, Switzerland, that their foundation would commit $10 billion over the next decade to research, develop and deliver vaccines for the world's poorest countries, the New York Times reports (McNeil, 1/29). The Gateses "said they hope the commitment would spur support by governments, corporations, and other donors for vaccinations efforts," the Chronicle of Philanthropy writes (Wilhelm, 1/29).

30 Jan 2010

Canada to donate 5m doses of H1N1 vaccine to WHO; agency has received commitment of 200m vaccines

The Canadian government on Thursday announced the country would donate five million doses of H1N1 vaccines to the WHO from the country's current surplus, the Canadian Press reports (Branswell, 1/28).

30 Jan 2010

Recent releases in Global Health

Rajiv Shah's appointment as USAID administrator "comes at a crucial time of challenge and opportunity for the Agency to improve the nutritional well-being of impoverished societies," write the authors of a Lancet Comment that examines the U.S. Global Hunger and Food Security Initiative. Though the initiative "sends a clear message to the world about U.S. intent to partner with poor nations to achieve their national food and nutrition goals … the Initiative's nutrition plan, unlike its detailed agricultural blueprint, currently lacks a comprehensive set of aims, activities, research needs, and programme benchmarks," the authors write.

29 Jan 2010

Bill & Melinda Gates Foundation commits $10 billion for vaccine research and development

Bill and Melinda Gates announced today that their foundation will commit $10 billion over the next 10 years to help research, develop and deliver vaccines for the world's poorest countries.

29 Jan 2010

Global market for oncology drugs is forecast to reach $80 billion by 2050

New Medicine's Oncology KnowledgeBASE (nm/OK) residing at http://nmok.net became available on the Internet 10 years ago and, since then, the oncology field has evolved into one of the most challenging, complex and promising drug development sectors, both in terms of its potential contribution to medicine and to its market opportunities.

29 Jan 2010

Vaccine News and Research

Latest Vaccine News and Research

PATH to pay FDA $480,000 to speed creation of pneumococcal vaccine for developing world

Obama's FY 2011 budget gives global health funding boost

Obama's budget includes a tempered vision of health reform

Global AIDS Alliance calls for Congress to fully fund the Global Health Initiative

Cryogenetics invents a method for cryo-preservation of fish embryos

Scientists find that protease HtrA2 can "clean" cells of oncogene WT1

New therapeutic made from tobacco plants shown to arrest West Nile virus infection

President's fiscal year 2011 budget: FDA requests $4.03 billion for promoting and protecting public health

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

FDA and PATH collaborate to advance pneumococcal vaccine development for children

Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds

Romark Laboratories commences enrollment in Alinia clinical trial for acute uncomplicated influenza

WHO pneumonia expert honored with PACE Global Leadership Award

PATH praises Gates Foundation for supporting vaccine development and delivery

New vaccine effective in preventing TB in HIV patients

At World Economic Forum, Gates Foundation announces 10-year, $10B vaccine commitment

Canada to donate 5m doses of H1N1 vaccine to WHO; agency has received commitment of 200m vaccines

Recent releases in Global Health

Bill & Melinda Gates Foundation commits $10 billion for vaccine research and development

Global market for oncology drugs is forecast to reach $80 billion by 2050

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in